This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the Company's ability to leverage the new research findings in commercial discussions; that the Company's platform can sustain outcomes beyond medication use; that the Company's solutions will maximize return on investment for health plans and employers implementing costly GLP-1 programs; the belief that the Company's AI research will translate to commercial value; and that the Company's solutions have the potential to drive both clinical outcomes and business results.